Calls for an Avandia recall are increasing. The latest has come from Rep. Rosa DeLauro (D., Conn.), the chairwoman of the House appropriations panel that controls the FDA’s budget, is the latest to call on the agency to do so.
According to The Wall Street Journal, DeLauro said yesterday that it is “reprehensible that many people might have suffered heart attacks or heart failure as a result of taking this drug, especially if a safer alternative exists.”
(more…)

